Pieper is now working to advance P7C3-A20 through Glengary Brain Health, a Cleveland-based company that he cofounded, according to the release. Pieper’s team had previously found that the ...
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
A high-fat diet forces liver cells to adapt for survival rather than function, creating metabolic stress that affects ...
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
Antigen-driven TCR signaling in the epidermis during CD8+ TRM differentiation results in a lower TGFβ requirement for persistence and increased proliferative capacity that together enhance epidermal ...
PowerCell Group has received a follow-up order valued at SEK 12 million from a leading European aerospace research institute. The order comprises four 100 kW fuel-cell systems engineered as modular un ...
Maintaining CDK4/6 inhibition constrains drug‑resistant breast tumors by delaying cell‑cycle entry, and adding CDK2 inhibition further deepens control to guide post‑progression therapy.
Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a significant acceleration of its longevity and ...
An Introduction to Doing Business in China 2026 is designed to guide new and established investors in China with updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback